Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 33,483
  • Shares Outstanding, K 88,440
  • Annual Sales, $ 0 K
  • Annual Income, $ -120 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/21/18
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0910 +335.05%
on 08/08/18
0.4996 -20.76%
on 08/09/18
+0.0182 (+4.82%)
since 07/13/18
3-Month
0.0910 +335.05%
on 08/08/18
0.6400 -38.14%
on 05/21/18
+0.1672 (+73.11%)
since 05/14/18
52-Week
0.0470 +742.34%
on 08/16/17
2.4600 -83.91%
on 12/29/17
+0.2484 (+168.41%)
since 08/11/17

Most Recent Stories

More News
Pivot Monetizes "RTIC" Technology And Enters Nevada Cannabis Market With Strategic Partner

Transaction Includes Licensing, Manufacturing, Co-marketing and Distribution Agreements

PVOTF : 0.3959 (+4.57%)
Pivot Acquires Rights To Patented Solumer™ Oral Drug Delivery Technology Ideal For Use In Cannabis-Infused Beverage Formulations

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Definitive Agreement with Israeli-based SoluBest Ltd. to acquire...

PVOTF : 0.3959 (+4.57%)
Pivot Acquires Rights To Patented Solumer™ Oral Drug Delivery Technology Ideal For Use In Cannabis-Infused Beverage Formulations

VANCOUVER , Aug. 7, 2018 /PRNewswire/ - Pivot Pharmaceuticals Inc . (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT ) ("Pivot" or the "Company") is pleased to announce that it has signed a...

PVOTF : 0.3959 (+4.57%)
Pivot Signs Exclusive Co-Marketing And Distribution Agreement with Swiss-based S.T.U. GmbH, Establishes Large Retail and Online Sales Channels In The European Union

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has entered into a Definitive Co-marketing and Distribution Agreement ("the Agreement")...

PVOTF : 0.3959 (+4.57%)
Pivot Pharma To File Investigational New Drug (IND) Application With U.S. FDA For PVT-005

Cannabinoid Topical Cream For Treatment Of Female Hypoactive Sexual Desire Disorder

PVOTF : 0.3959 (+4.57%)
Pivot Pharma To File Investigational New Drug (IND) Application With U.S. FDA For PVT-005

Cannabinoid Topical Cream For Treatment Of Female Hypoactive Sexual Desire Disorder

PVOTF : 0.3959 (+4.57%)
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair™ Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has signed an Option Agreement with IP Med Inc., based in Oceanside,...

PVOTF : 0.3959 (+4.57%)
Pivot Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc.

Bio-Cannabis Product Pipeline Ready To Be Commercialized In Canada

PVOTF : 0.3959 (+4.57%)
Pivot Signs Exclusive Manufacturing Agreement with Bio V Pharma Inc.

Bio-Cannabis Product Pipeline Ready To Be Commercialized In Canada

PVOTF : 0.3959 (+4.57%)
Pivot Secures Manufacturing Facility in Costa Mesa, California

U.S. Subsidiary Pivot Naturals LLC To Submit Applications For Cannabis Business Licenses

PVOTF : 0.3959 (+4.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade PVOTF with:

Key Turning Points

2nd Resistance Point 0.4346
1st Resistance Point 0.4153
Last Price 0.3959
1st Support Level 0.3723
2nd Support Level 0.3486

See More

52-Week High 2.4600
Fibonacci 61.8% 1.5382
Fibonacci 50% 1.2535
Fibonacci 38.2% 0.9688
Last Price 0.3959
52-Week Low 0.0470

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar